Literature DB >> 21695767

Type 2 diabetes affects hippocampus volume differentially in men and women.

R Hempel1, R Onopa, Antonio Convit.   

Abstract

BACKGROUND: Type 2 diabetes mellitus (T2DM) has been shown to result in medical complications on several organ systems including the kidneys, eyes, cardiovascular system, and most recently described the brain, including the hippocampus. There is also evidence that females are disproportionately affected by these medical complications. Brain volume reductions have also been associated with chronic low-grade inflammation and dyslipidaemia. This study investigated the relationships among T2DM, gender, inflammation, dyslipidaemia, and hippocampal volumes.
METHOD: Participant groups consisted of 40 obese adults with T2DM and 47 lean adults, group-matched on age, gender, race, and education. Each participant underwent medical examination including a standard panel of blood tests, a magnetic resonance imaging, and cognitive evaluation.
RESULTS: We show that there is a gender difference in the association of T2DM and hippocampal volumes: diabetic women are most affected despite having better glucose control than their male counterparts. Although females with T2DM had disproportionately lower high density lipoprotein as well as better haemoglobin A1c, neither of these results explained why females with T2DM had the smallest hippocampal volumes.
CONCLUSIONS: These important findings indicate that in addition to the higher rate of traditional medical complication, females with T2DM are likely to suffer more brain complications than males. These observations, if supported by larger studies, suggest that in the future gender could be considered when customizing diabetes treatment.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 21695767      PMCID: PMC3273865          DOI: 10.1002/dmrr.1230

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  46 in total

Review 1.  The role of neuronal signaling in controlling cerebral blood flow.

Authors:  Carrie T Drake; Costantino Iadecola
Journal:  Brain Lang       Date:  2006-09-28       Impact factor: 2.381

2.  Sex differences in inflammatory markers: what is the contribution of visceral adiposity?

Authors:  Amélie Cartier; Mélanie Côté; Isabelle Lemieux; Louis Pérusse; Angelo Tremblay; Claude Bouchard; Jean-Pierre Després
Journal:  Am J Clin Nutr       Date:  2009-03-18       Impact factor: 7.045

Review 3.  Dyslipidemia in type 2 diabetes mellitus.

Authors:  Arshag D Mooradian
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2009-03

4.  High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus.

Authors:  Brian G Drew; Stephen J Duffy; Melissa F Formosa; Alaina K Natoli; Darren C Henstridge; Sally A Penfold; Walter G Thomas; Nigora Mukhamedova; Barbora de Courten; Josephine M Forbes; Felicia Y Yap; David M Kaye; Gerrit van Hall; Mark A Febbraio; Bruce E Kemp; Dmitri Sviridov; Gregory R Steinberg; Bronwyn A Kingwell
Journal:  Circulation       Date:  2009-04-06       Impact factor: 29.690

5.  Plasma BDNF is reduced among middle-aged and elderly women with impaired insulin function: evidence of a compensatory mechanism.

Authors:  Alyssa Arentoft; Victoria Sweat; Vanessa Starr; Stephen Oliver; Jason Hassenstab; Hannah Bruehl; Aziz Tirsi; Elizabeth Javier; Pauline F McHugh; Antonio Convit
Journal:  Brain Cogn       Date:  2009-05-28       Impact factor: 2.310

6.  Cerebrovascular reactivity is impaired in patients with non-insulin-dependent diabetes mellitus and microangiopathy.

Authors:  Ligia Petrica; Maxim Petrica; Adrian Vlad; Flaviu Bob; Cristina Gluhovschi; Gheorghe Gluhovschi; Catalin D Jianu; Sorin Ursoniu; Adalbert Schiller; Silvia Velciov; Virginia Trandafirescu; Gheorghe Bozdog
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

7.  The Impact of type 2 diabetes on mortality in end-stage renal disease patients differs between genders.

Authors:  A Karamé; M Labeeuw; P Trolliet; A Caillette-Beaudoin; R Cahen; R Ecochard; R Galland; P Hallonet; C Pouteil-Noble; E Villar
Journal:  Nephron Clin Pract       Date:  2009-06-16

8.  A blunted cortisol awakening response and hippocampal atrophy in type 2 diabetes mellitus.

Authors:  Hannah Bruehl; Oliver T Wolf; Antonio Convit
Journal:  Psychoneuroendocrinology       Date:  2009-01-24       Impact factor: 4.905

9.  Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus.

Authors:  Hannah Bruehl; Oliver T Wolf; Victoria Sweat; Aziz Tirsi; Stephen Richardson; Antonio Convit
Journal:  Brain Res       Date:  2009-05-20       Impact factor: 3.252

Review 10.  Mechanisms of fibrinogen-induced microvascular dysfunction during cardiovascular disease.

Authors:  D Lominadze; W L Dean; S C Tyagi; A M Roberts
Journal:  Acta Physiol (Oxf)       Date:  2009-09-01       Impact factor: 6.311

View more
  18 in total

1.  Fasting plasma insulin and the default mode network in women at risk for Alzheimer's disease.

Authors:  Heather Kenna; Fumiko Hoeft; Ryan Kelley; Tonita Wroolie; Bevin DeMuth; Allan Reiss; Natalie Rasgon
Journal:  Neurobiol Aging       Date:  2012-07-06       Impact factor: 4.673

2.  Obesity, fitness, and brain integrity in adolescence.

Authors:  Naima Ross; Po Lai Yau; Antonio Convit
Journal:  Appetite       Date:  2015-04-02       Impact factor: 3.868

3.  Middle-Aged Diabetic Females and Males Present Distinct Susceptibility to Alzheimer Disease-like Pathology.

Authors:  E Candeias; A I Duarte; I Sebastião; M A Fernandes; A I Plácido; C Carvalho; S Correia; R X Santos; R Seiça; M S Santos; C R Oliveira; P I Moreira
Journal:  Mol Neurobiol       Date:  2016-10-11       Impact factor: 5.590

Review 4.  Shared neurobiological pathways between type 2 diabetes and depressive symptoms: a review of morphological and neurocognitive findings.

Authors:  Todd Doyle; Angelos Halaris; Murali Rao
Journal:  Curr Diab Rep       Date:  2014-12       Impact factor: 4.810

5.  Amylin-induced downregulation of hippocampal neurogenesis is attenuated by leptin in a STAT3/AMPK/ERK-dependent manner in mice.

Authors:  H-S Moon; F Dincer; C S Mantzoros
Journal:  Diabetologia       Date:  2012-12-09       Impact factor: 10.122

Review 6.  Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums.

Authors:  Steven E Arnold; Zoe Arvanitakis; Shannon L Macauley-Rambach; Aaron M Koenig; Hoau-Yan Wang; Rexford S Ahima; Suzanne Craft; Sam Gandy; Christoph Buettner; Luke E Stoeckel; David M Holtzman; David M Nathan
Journal:  Nat Rev Neurol       Date:  2018-01-29       Impact factor: 42.937

Review 7.  Neuroactive Steroids and Sex-Dimorphic Nervous Damage Induced by Diabetes Mellitus.

Authors:  Silvia Giatti; Silvia Diviccaro; Roberto Cosimo Melcangi
Journal:  Cell Mol Neurobiol       Date:  2018-08-14       Impact factor: 5.046

8.  Does obesity-associated insulin resistance affect brain structure and function of adolescents differentially by sex?

Authors:  Andrea Gabay; Stephanie London; Kathy F Yates; Antonio Convit
Journal:  Psychiatry Res Neuroimaging       Date:  2021-11-24       Impact factor: 2.376

9.  Resting-state brain functional connectivity is altered in type 2 diabetes.

Authors:  Gail Musen; Alan M Jacobson; Nicolas R Bolo; Donald C Simonson; Martha E Shenton; Richard L McCartney; Veronica L Flores; Wouter S Hoogenboom
Journal:  Diabetes       Date:  2012-06-04       Impact factor: 9.461

Review 10.  Allopregnanolone: An overview on its synthesis and effects.

Authors:  Silvia Diviccaro; Lucia Cioffi; Eva Falvo; Silvia Giatti; Roberto Cosimo Melcangi
Journal:  J Neuroendocrinol       Date:  2021-06-29       Impact factor: 3.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.